P313: A case report of an Egyptian family with hypercholesterolemia diagnosed with a unique LINE-1 insertion in the LDLR gene

P313: A case report of an Egyptian family with hypercholesterolemia diagnosed with a unique LINE-1 insertion in the LDLR gene

Bibliographic Details
Main Authors:	Yongjun Song, Reham Elwafa, Omneya Omar, Hane Lee, Go Hun Seo
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423003412

Similar Items

A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE‐1 insertion in LDLR
by: Yongjun Song, et al.
Published: (2024-03-01)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
by: Ma S, et al.
Published: (2019-08-01)

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
by: Kaihan Wang, et al.
Published: (2024-03-01)

LDLR gene’s promoter region hypermethylation in patients with familial hypercholesterolemia
by: R. A. Zorzo, et al.
Published: (2023-06-01)

Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
by: Haochang Hu, et al.
Published: (2021-12-01)

Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.
by: Bryan T Davis, et al.
Published: (2014-01-01)

Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia
by: Praseetha Kizhakkedath, et al.
Published: (2019-11-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Genomic characterization of large rearrangements of the <it>LDLR </it>gene in Czech patients with familial hypercholesterolemia
by: Fajkus Jiří, et al.
Published: (2010-07-01)

Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia
by: Xian Lv, et al.
Published: (2023-10-01)

In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia
by: Shaoyi Lin, et al.
Published: (2023-06-01)

A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family.
by: Hongyan Shu, et al.
Published: (2017-01-01)

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes
by: Robert Derenbecker, MD, et al.
Published: (2019-10-01)

Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia
by: Jian Wang, et al.
Published: (2005-02-01)

Physiologically-regulated low density lipoprotein receptor (LDLR) expression vectors for the treatment of familial hypercholesterolemia
by: Hibbitt, O, et al.
Published: (2008)

Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights
by: Mohammad Athar, et al.
Published: (2023-07-01)

LDLR and ApoB are Major Genetic Causes of Autosomal Dominant Hypercholesterolemia in a Taiwanese Population
by: Kai-Chien Yang, et al.
Published: (2007-10-01)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
by: Muhammad Idrees, et al.
Published: (2018-07-01)

Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S]
by: Elizabeth A. O'Hare, et al.
Published: (2014-11-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
by: V. B. Vasilyev, et al.
Published: (2022-06-01)

iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia
by: Irina S. Zakharova, et al.
Published: (2024-01-01)

Allicin and Capsaicin Ameliorated Hypercholesterolemia by Upregulating LDLR and Downregulating PCSK9 Expression in HepG2 Cells
by: Nantiya Nawaka, et al.
Published: (2022-11-01)

Erratum: Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
Published: (2019-05-01)

Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
by: Say-Hean Lye, et al.
Published: (2013-01-01)

Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
by: Takahito Doi, et al.
Published: (2021-02-01)

A Rare Missense Mutation and a Polymorphism with High Frequency in LDLR Gene among Iranian Patients with Familial Hypercholesterolemia
by: Masoud Tajamolian, et al.
Published: (2018-01-01)

Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred1
by: L. Haddad, et al.
Published: (1999-06-01)

Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia
by: Arman Moradi, et al.
Published: (2021-02-01)

1. Founder mutation identified in the LDLR gene causing familial hypercholesterolemia associated with increased risk of coronary heart disease
by: Faisal Al-Allaf, et al.
Published: (2017-10-01)

An LDLR missense variant poses high risk of familial hypercholesterolemia in 30% of Greenlanders and offers potential of early cardiovascular disease intervention
by: Jørsboe, E, et al.
Published: (2022)

The <i>LDLR</i>, <i>APOB</i>, and <i>PCSK9</i> Variants of Index Patients with Familial Hypercholesterolemia in Russia
by: Alexey Meshkov, et al.
Published: (2021-01-01)

4. Identification of a novel nonsense variant C.1332DUP, P. (D445*) in the LDLR gene that causes familial hypercholesterolemia
by: Faisal Al-Allaf, et al.
Published: (2017-10-01)

Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7Research in context section
by: Rui Lu, et al.
Published: (2018-10-01)

Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia – a preliminary report
by: C. S. Paththinige, et al.
Published: (2018-05-01)

Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen
by: Zuhier Ahmed Awan, et al.
Published: (2021-06-01)

An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene
by: Kui Zhu, et al.
Published: (2023-09-01)

Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor
by: Burabha Pussadhamma, et al.
Published: (2024-03-01)

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
by: Yanfang Yang, et al.
Published: (2023-03-01)

Induced pluripotent stem cell line ICGi037-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to heterozygous p.Trp443Arg mutations in LDLR
by: Irina S. Zakharova, et al.
Published: (2022-04-01)

GRP78/BiP alleviates oxLDL-induced hepatotoxicity in familial hypercholesterolemia caused by missense variants of LDLR in a HepG2 cellular model
by: Divya Saro Varghese, et al.
Published: (2023-05-01)